Zydus Lifesciences receives final approval from US FDA for Adapalene and Benzoyl Peroxide Topical Gel Read more
Zydus announces publication of “Dream-ND” and “Dream-D” phase-III trials of Desidustat in “American Journal of Nephrology” Read more